71 related articles for article (PubMed ID: 2753980)
1. Estrogen 2-hydroxylase oxidation and menstrual function among elite oarswomen.
Snow RC; Barbieri RL; Frisch RE
J Clin Endocrinol Metab; 1989 Aug; 69(2):369-76. PubMed ID: 2753980
[TBL] [Abstract][Full Text] [Related]
2. Magnetic resonance imaging of overall and regional body fat, estrogen metabolism, and ovulation of athletes compared to controls.
Frisch RE; Snow RC; Johnson LA; Gerard B; Barbieri R; Rosen B
J Clin Endocrinol Metab; 1993 Aug; 77(2):471-7. PubMed ID: 8345054
[TBL] [Abstract][Full Text] [Related]
3. Biotransformation of estradiol by explant culture of human mammary tissue.
Telang NT; Axelrod DM; Wong GY; Bradlow HL; Osborne MP
Steroids; 1991 Jan; 56(1):37-43. PubMed ID: 2028481
[TBL] [Abstract][Full Text] [Related]
4. Monitoring of ovarian activity by daily measurement of urinary excretion rates of oestrone glucuronide and pregnanediol glucuronide using the Ovarian Monitor, Part III: variability of normal menstrual cycle profiles.
Blackwell LF; Vigil P; Cooke DG; d'Arcangues C; Brown JB
Hum Reprod; 2013 Dec; 28(12):3306-15. PubMed ID: 24170744
[TBL] [Abstract][Full Text] [Related]
5. Participation in leanness sports but not training volume is associated with menstrual dysfunction: a national survey of 1276 elite athletes and controls.
Torstveit MK; Sundgot-Borgen J
Br J Sports Med; 2005 Mar; 39(3):141-7. PubMed ID: 15728691
[TBL] [Abstract][Full Text] [Related]
6. High frequency of luteal phase deficiency and anovulation in recreational women runners: blunted elevation in follicle-stimulating hormone observed during luteal-follicular transition.
De Souza MJ; Miller BE; Loucks AB; Luciano AA; Pescatello LS; Campbell CG; Lasley BL
J Clin Endocrinol Metab; 1998 Dec; 83(12):4220-32. PubMed ID: 9851755
[TBL] [Abstract][Full Text] [Related]
7. Elevated 4-hydroxylation of estradiol by hamster kidney microsomes: a potential pathway of metabolic activation of estrogens.
Weisz J; Bui QD; Roy D; Liehr JG
Endocrinology; 1992 Aug; 131(2):655-61. PubMed ID: 1386303
[TBL] [Abstract][Full Text] [Related]
8. Bone health is not affected by luteal phase abnormalities and decreased ovarian progesterone production in female runners.
De Souza MJ; Miller BE; Sequenzia LC; Luciano AA; Ulreich S; Stier S; Prestwood K; Lasley BL
J Clin Endocrinol Metab; 1997 Sep; 82(9):2867-76. PubMed ID: 9284712
[TBL] [Abstract][Full Text] [Related]
9. Increased estrogen-16 alpha-hydroxylase activity in women with breast and endometrial cancer.
Fishman J; Schneider J; Hershcope RJ; Bradlow HL
J Steroid Biochem; 1984 Apr; 20(4B):1077-81. PubMed ID: 6727352
[TBL] [Abstract][Full Text] [Related]
10. Plasma endothelin and LH-RH, LH, FSH, prolactin, progesterone, 17alpha-hydroxyprogesterone, estrone, 17beta-estradiol, delta4-androstenedione, testosterone, active renin, angiotensin-II and ANP levels in blood and LH, estrone and 17beta-estradiol and pregnanediol levels in urine of normal cycling women.
Usuki S; Kondoh K; Kubo T
J Cardiovasc Pharmacol; 2000 Nov; 36(5 Suppl 1):S421-7. PubMed ID: 11078439
[TBL] [Abstract][Full Text] [Related]
11. High prevalence of subtle and severe menstrual disturbances in exercising women: confirmation using daily hormone measures.
De Souza MJ; Toombs RJ; Scheid JL; O'Donnell E; West SL; Williams NI
Hum Reprod; 2010 Feb; 25(2):491-503. PubMed ID: 19945961
[TBL] [Abstract][Full Text] [Related]
12. The effect of the phase of the menstrual cycle and the birth control pill on athletic performance.
Lebrun CM
Clin Sports Med; 1994 Apr; 13(2):419-41. PubMed ID: 8013042
[TBL] [Abstract][Full Text] [Related]
13. Late luteal phase administration of RU486 for three successive cycles does not disrupt bleeding patterns or ovulation.
Croxatto HB; Salvatierra AM; Romero C; Spitz IM
J Clin Endocrinol Metab; 1987 Dec; 65(6):1272-7. PubMed ID: 3119656
[TBL] [Abstract][Full Text] [Related]
14. Postpartum return of ovarian activity in nonbreastfeeding women monitored by urinary assays.
Gray RH; Campbell OM; Zacur HA; Labbok MH; MacRae SL
J Clin Endocrinol Metab; 1987 Apr; 64(4):645-50. PubMed ID: 3818896
[TBL] [Abstract][Full Text] [Related]
15. Elevated estrogen 16 alpha-hydroxylase activity: is this a genotoxic or nongenotoxic biomarker in human breast cancer risk?
Nebert DW
J Natl Cancer Inst; 1993 Dec; 85(23):1888-91. PubMed ID: 8230275
[No Abstract] [Full Text] [Related]
16. The influence of dietary protein and carbohydrate on the principal oxidative biotransformations of estradiol in normal subjects.
Anderson KE; Kappas A; Conney AH; Bradlow HL; Fishman J
J Clin Endocrinol Metab; 1984 Jul; 59(1):103-7. PubMed ID: 6725517
[TBL] [Abstract][Full Text] [Related]
17. Quercetin increases the severity of estradiol-induced tumorigenesis in hamster kidney.
Zhu BT; Liehr JG
Toxicol Appl Pharmacol; 1994 Mar; 125(1):149-58. PubMed ID: 8128490
[TBL] [Abstract][Full Text] [Related]
18. [Estradiol-2-hydroxylase activity in tumors of the corpus uteri and breast: the effect of smoking].
Tsyrlina EV; Manikhas (Kolesnik) OS; Vasil'ev DA; Kovalenko IG; Bershteĭn LM
Vopr Onkol; 2000; 46(3):306-10. PubMed ID: 10976277
[TBL] [Abstract][Full Text] [Related]
19. Catechol estrogen formation by brain tissue: a comparison of the release of tritium from [2-3H]estradiol with [6,7-3H]2-hydroxyestradiol formation from [6,7-3H]estradiol by rabbit hypothalami in vitro.
Hersey RM; Gunsalus P; Lloyd T; Weisz J
Endocrinology; 1981 Dec; 109(6):1902-11. PubMed ID: 6273121
[TBL] [Abstract][Full Text] [Related]
20. Spinal bone loss and ovulatory disturbances.
Prior JC; Vigna YM; Schechter MT; Burgess AE
N Engl J Med; 1990 Nov; 323(18):1221-7. PubMed ID: 2215605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
